News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
High mortgage rates are keeping more households in rentals, supporting multifamily demand even as Sun Belt oversupply pressures owners.
DBS (SGX: D05) and Citi (NYSE: $C) have completed a cross-border US dollar payment between Singapore and the United...
Playing an official part in the IPO process could give Robinhood more influence over the number of shares allocated to its customers.
Citigroup is nearing a China brokerage license that could deepen client ties and help raise investment-banking wallet share above 6%. Can it boost growth?
Strong earnings momentum, a solid capital cushion and ample buyback capacity are underpinning BAC's shareholder-return strategy.
Find out what you can save by waiting.
Lifestyle creep is less forgiving in retirement.
Strong August jobs data raised rate-hike odds ahead of the Fed's September meeting. IWM, XLF, and TLT offer different ways for investors to position for the decision's outcome.
The stark reality in 2026 is that $1.5 million can either be excellent or insufficient depending on a wide range of factors that stretch beyond the spreadsheet.
Highly public CEOs can be good or bad for a business, but sometimes, even when things are good, they can be bad.
Banks are racing to automate financial decisions, and new data shows most Americans are fine with that, until there is no one left to call.
Mellody Hobson co-founded the $1 billion Lucas Museum of Narrative Art while her bank pushes tokenized money onchain.
Recent research on WEG has sharpened the focus on price targets, with JPMorgan setting a R$56 level and Goldman Sachs at R$42.60. These moves reflect a clear split in analyst views, where some see improving momentum and valuation support, while others point to execution risks around future growth expectations. As you read on, you will see how these differing targets feed into the evolving narrative around WEG and what to watch as sentiment shifts. Stay updated as the Fair Value for WEG shifts...
Anthropic could give Morgan Stanley (MS) and Goldman Sachs (GS) key roles in handling its market deb
SOFI's Payward tie-up expands SoFiUSD's reach through Kraken while adding digital-asset liquidity and 24/7 dollar clearing.
A resilient labor market can support interest income while increasing credit, valuation and policy risks.
Amneal Pharmaceuticals is back in focus after analysts lifted fair value from US$20.25 to US$21.00 per share, reflecting updated assumptions in recent models. Much of this shift lines up with Street research that leans positive on growth, execution, and the potential from new product launches and a broader portfolio. Keep reading to see what is changing in the narrative around Amneal Pharmaceuticals and how you can track those moving parts over time. Stay updated as the Fair Value for Amneal...
EverQuote has seen its assessed fair value move from US$25.83 to US$29.50, a change that puts fresh attention on where analysts think the stock could reasonably trade. Recent commentary, including targets in the US$28 to US$34 range and JPMorgan's US$29 mark, links this shift to views on the company’s insurance marketplace plans and execution. As you read on, you will see how this evolving narrative might shape the way you track EverQuote from here. Stay updated as the Fair Value for...
You might want to consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio to maximize your returns.
PG&E's fair value estimate has been cut from US$22.59 to US$20.78, an 8% pullback that resets the price target used in one key valuation framework. This shift aligns with a research backdrop where analysts are split, with targets now spread from about US$13 to US$28 as views differ on wildfire liability, capital plans and how policy risk should be priced. As you read on, you will see how these moving targets shape the current PG&E story and what to watch as the narrative continues to...
Prudential Financial is back in focus after the latest model refresh nudged its fair value estimate to US$113.40 from US$110.53. Recent analyst research has clustered price targets for Prudential Financial in a broad US$110 to US$131 range, reflecting a mix of optimism and caution around valuation, earnings power, and execution risk. As you read on, you will see how to track these shifting targets and what they might mean for your own view of the stock over time. Analyst Price Targets don't...
An analyst upgraded his recommendation on the auto marketplace company.
JPMorgan Chase & Co. (JPM) closed the most recent trading day at $362.06, moving +1.64% from the previous trading session.
September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare over growth stocks.
MKTX's international expansion, platform innovation and strong cash generation support growth, but U.S. credit weakness and valuation warrant caution.
The difference between your benefit check and someone else’s could be hundreds of dollars. Here’s a full breakdown by age.
Bringing some of Altruist’s AI financial planning tech to Vanguard Digital Advisor may be a core reason the asset manager made the offer in the first place.